Marker Therapeutics
MRKR

Marker Therapeutics (MRKR) news

Recent news

ImportantMarker Therapeutics Shares Rise 10% After Positive Trial Data for MT-601

AInvest Wire · Sep 11, 2023

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.